207 related articles for article (PubMed ID: 20061606)
1. Apolipoprotein E promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis.
Xin XY; Ding JQ; Chen SD
J Alzheimers Dis; 2010; 19(4):1283-94. PubMed ID: 20061606
[TBL] [Abstract][Full Text] [Related]
2. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
[TBL] [Abstract][Full Text] [Related]
3. APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss.
Laws SM; Clarnette RM; Taddei K; Martins G; Paton A; Hallmayer J; Almeida OP; Groth DM; Gandy SE; Förstl H; Martins RN
Mol Psychiatry; 2002; 7(7):768-75. PubMed ID: 12192621
[TBL] [Abstract][Full Text] [Related]
4. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population.
Zurutuza L; Verpillat P; Raux G; Hannequin D; Puel M; Belliard S; Michon A; Pothin Y; Camuzat A; Penet C; Martin C; Brice A; Campion D; Clerget-Darpoux F; Frebourg T
Eur J Hum Genet; 2000 Sep; 8(9):713-6. PubMed ID: 10980578
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
[TBL] [Abstract][Full Text] [Related]
6. An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease.
Lescai F; Chiamenti AM; Codemo A; Pirazzini C; D'Agostino G; Ruaro C; Ghidoni R; Benussi L; Galimberti D; Esposito F; Marchegiani F; Cardelli M; Olivieri F; Nacmias B; Sorbi S; Tagliavini F; Albani D; Martinelli Boneschi F; Binetti G; Santoro A; Forloni G; Scarpini E; Crepaldi G; Gabelli C; Franceschi C
J Alzheimers Dis; 2011; 24(2):235-45. PubMed ID: 21263195
[TBL] [Abstract][Full Text] [Related]
7. Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study.
Roks G; Cruts M; Houwing-Duistermaat JJ; Dermaut B; Serneels S; Havekes LM; Hofman A; Breteler MM; Van Broeckhoven C; van Duijn CM
Am J Med Genet; 2002 Jul; 114(5):570-3. PubMed ID: 12116196
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
[TBL] [Abstract][Full Text] [Related]
9. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
10. Association between somatostatin gene polymorphisms and sporadic Alzheimer's disease in Chinese population.
Xue S; Jia L; Jia J
Neurosci Lett; 2009 Nov; 465(2):181-3. PubMed ID: 19733630
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of APOE and LRP genes in Brazilian individuals with Alzheimer disease.
Bahia VS; Kok F; Marie SN; Shinjo SO; Caramelli P; Nitrini R
Alzheimer Dis Assoc Disord; 2008; 22(1):61-5. PubMed ID: 18317248
[TBL] [Abstract][Full Text] [Related]
12. Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes.
Bray NJ; Jehu L; Moskvina V; Buxbaum JD; Dracheva S; Haroutunian V; Williams J; Buckland PR; Owen MJ; O'Donovan MC
Hum Mol Genet; 2004 Nov; 13(22):2885-92. PubMed ID: 15385439
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in alpha(1)-antichymotrypsin and its association with Alzheimer's disease.
Wang X; DeKosky ST; Luedecking-Zimmer E; Ganguli M; Kamboh MI
Hum Genet; 2002 Apr; 110(4):356-65. PubMed ID: 11941486
[TBL] [Abstract][Full Text] [Related]
14. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW
Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457
[TBL] [Abstract][Full Text] [Related]
15. Association of RFC1 A80G and MTHFR C677T polymorphisms with Alzheimer's disease.
Bi XH; Zhao HL; Zhang ZX; Zhang JW
Neurobiol Aging; 2009 Oct; 30(10):1601-7. PubMed ID: 18258338
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease.
Wang B; Zhou S; Yang Z; Xie YC; Wang J; Zhang P; Lv Z; Zheng C; Ma X
J Neurol Sci; 2008 Jul; 270(1-2):148-51. PubMed ID: 18396294
[TBL] [Abstract][Full Text] [Related]
17. Age at onset: an essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease.
Beyer K; Lao JI; Latorre P; Ariza A
Ann N Y Acad Sci; 2005 Dec; 1057():260-78. PubMed ID: 16399900
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity.
Nacmias B; Bagnoli S; Tedde A; Cellini E; Bessi V; Guarnieri B; Ortensi L; Piacentini S; Bracco L; Sorbi S
Arch Gerontol Geriatr; 2007; 45(2):201-6. PubMed ID: 17182125
[TBL] [Abstract][Full Text] [Related]
20. Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene as risk factors for Alzheimer's disease.
Bratosiewicz-Wasik J; Liberski PP; Peplonska B; Styczynska M; Smolen-Dzirba J; Cycon M; Wasik TJ
Neurosci Lett; 2018 Sep; 684():86-90. PubMed ID: 29990559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
